Carl Williams
Ask VT AI
View News Summary
- Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
- Milei's party projected to maintain veto power in Argentina's midterm elections, with gains in both chambers of Congress.
- Hong Kong court sentences trio for 2019-2020 bomb plots aimed at forcing border closures during COVID-19 pandemic.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
- Milei's party projected to maintain veto power in Argentina's midterm elections, with gains in both chambers of Congress.
- Hong Kong court sentences trio for 2019-2020 bomb plots aimed at forcing border closures during COVID-19 pandemic.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Carl Williams
News from Carl Williams
